...
首页> 外文期刊>Neuromuscular disorders: NMD >Renal function in children and adolescents with Duchenne muscular dystrophy
【24h】

Renal function in children and adolescents with Duchenne muscular dystrophy

机译:小儿杜氏肌营养不良症的儿童和青少年的肾功能

获取原文
获取原文并翻译 | 示例
           

摘要

Improved life expectancy and the need for robust tools to monitor renal safety of emerging new therapies have fueled the interest in renal function in Duchenne muscular dystrophy (DMD) patients. We aimed to establish a methodology to accurately assess their renal function. Twenty DIVED patients (5-22 years) were included in this prospective study. After obtaining medical history, all patients underwent a clinical examination, 24-hour ambulatory blood pressure monitoring, ultrasound of the kidneys, direct GFR measurement (Cr-51-EDTA, mGFR), complete blood and urine analysis. Seventeen of 20 patients were treated with corticosteroids and 5/20 with angiotensin converting enzyme inhibitor (lisinopril). No patient suffered from urinary tract infections or other renal diseases. Hypertension (systolic or diastolic blood pressure >P95) was found in 9/20 patients (8/9 patients were on steroid treatment) and a non-dipping blood pressure profile in 13/20 subjects (10/13 patients were on steroid treatment). Urinary protein to creatinine ratio was elevated in 17/18 patients, whereas 24-hour urine protein excretion was normal in all subjects. Median interquartile range (IQR) mGFR was 130.4 (29.1) mL/min/1.73 m(2). Hyperfiltration (mGFR >150 nit/min/1.73 m(2)) was found in 5/20 patients. Inverse correlation between mGFR and age was observed (R-2 = 0.45, p = 0.001). Serum creatinine based estimated GFR (eGFR) equations overestimated mGFR up to 300%. eGFR based on cystatin C Filler equation was closest to the mGFR (median eGFR (IQR) of 129.5 (39.7) mL/min/1.73 m(2)). Our study demonstrates. a high prevalence of hyperfiltration and hypertension in children and adolescents with DMD. Because the majority of hypertensive patients were under corticosteroid treatment, the iatrogenic cause of hypertension cannot be excluded. Serum or urine creatinine measurements are of no value to evaluate renal function in DMD patients due to the reduced skeletal muscle mass. (C) 2015 Elsevier B.V. All rights reserved.
机译:预期寿命的延长以及对监测新兴治疗方法肾脏安全性的强大工具的需求,激起了对杜氏肌营养不良(DMD)患者肾功能的关注。我们旨在建立一种准确评估其肾功能的方法。该前瞻性研究包括20名DIVED患者(5-22岁)。获得病史后,所有患者均接受临床检查,24小时动态血压监测,肾脏超声检查,直接GFR测量(Cr-51-EDTA,mGFR),全血和尿液分析。 20例患者中有17例接受皮质类固醇激素治疗,5/20例接受血管紧张素转化酶抑制剂(赖诺普利)治疗。没有患者患有尿路感染或其他肾脏疾病。在9/20患者中发现高血压(收缩压或舒张压> P95)(使用类固醇药物治疗的患者为8/9),在13/20患者中发现非浸渍性血压分布(使用类固醇药物治疗的患者为10​​/13) 。在17/18例患者中尿蛋白与肌酐的比率升高,而所有受试者中24小时尿蛋白排泄是正常的。四分位数间距(IQR)mGFR为130.4(29.1)mL / min / 1.73 m(2)。在5/20患者中发现了超滤现象(mGFR> 150 nit / min / 1.73 m(2))。观察到mGFR与年龄之间呈负相关(R-2 = 0.45,p = 0.001)。基于血清肌酐的估计GFR(eGFR)方程高估了mGFR高达300%。基于胱抑素C填料方程的eGFR最接近mGFR(eGFR中位数(IQR)为129.5(39.7)mL / min / 1.73 m(2))。我们的研究表明。 DMD儿童和青少年的超滤和高血压患病率很高。因为大多数高血压患者接受皮质类固醇激素治疗,所以不能排除高血压的医源性原因。由于骨骼肌质量降低,血清或尿肌酐的测量对评估DMD患者的肾功能没有价值。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号